MedCity News

Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss

Everything You Need to Know About Sterilization Cases and Their Role in Healthcare

Innovative sterilization cases and trays are instrumental in reducing infection risk in medical settings. Learn notable things about them and their makers.

By Jewel Precision

MedCity Influencers

When Dialysis Comes Home, Patients and Care Partners Flourish

When home dialysis is done right, care partners quickly discover they are becoming an integral part of the process as engaged, informed participants rather than uninformed outside observers. By knowing more, care partners can worry a lot less.

By Michael Aragon

MedCity Influencers

Harnessing Innovative Transplant Diagnostics to Improve Patient Outcomes

Innovative transplant diagnostics and novel paradigms that give a clearer picture of a recipient’s immune system at various phases of the transplant journey can enable transplant teams to mitigate some of these challenges and make more accurate and faster donor assessments, as well as more informed and patient-centric decisions post-transplant.

By Tina Liedtky

Latest News

BioPharma

Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder

Neurotech Pharmaceuticals’ surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). It’s the first therapy for this rare retinal degeneration disorder.

By Frank Vinluan

Artificial Intelligence, Startups, Health Tech

Inside Healthcare’s Hottest New AI Category: Agentic AI

Healthcare organizations are starting to implement AI agents — autonomous, task-specific systems designed to perform functions with little or no human intervention. While initial adoption is focused mainly on non-clinical areas like scheduling and prior authorizations, experts predict that AI agents could eventually play a role in clinical decision-making, provided they meet rigorous safety and reliability standards.

By Katie Adams

Sponsored Post

Webinar: Tips To Have Your Practice Succeed This Year

This on-demand webinar will offer insights and share tips on helping practices run more efficiently.

By Elation Health and MedCity News

Health Tech

Sunrise Introduces Sleep Offering Tailored to Women

With Sunrise's women’s health program, the company can support women battling sleep issues due to conditions like pregnancy, polycystic ovary syndrome, perimenopause, menopause and premenstrual syndrome.

By Marissa Plescia

MedCity Influencers

Navigating Diagnostic Deserts: How Portable Ultrasound is Improving Maternal Healthcare in Africa

Providing affordable point-of-care diagnostic tools can be instrumental in quickly and efficiently assessing the well-being of all people, especially pregnant mothers. This can empower healthcare providers to be better diagnosticians and improve overall patient care, particularly for those at risk.

By Sachita Shah

MedCity Influencers

Buprenorphine Access Still Lags, Even After Major Federal Policy Changes

While the drop in drug overdose deaths is promising, and could potentially be partially attributed to the efforts of the federal government, we must remain cognizant about the sheer number of lives we continue to lose every year to overdose.

By Suhanee Mitragotri

Artificial Intelligence Providers,

This Hospital Exec Wants Nurses to Join the Ambient Listening Party Too

Lavonia Thomas, nursing informatics officer at MD Anderson Cancer Center, hopes that nurses will gain more access to ambient listening tools that listen in on patient conversations and then generate summaries for documentation purposes. These AI tools have become popular among physicians in the past couple years.

By Katie Adams

BioPharma, Pharma

Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy

J&J said aticaprant showed insufficient efficacy in a Phase 3 test in major depressive disorder. The disappointing result follows the Phase 3 failure of a Neumora Therapeutics drug that addresses the same central nervous system target.

By Frank Vinluan

Sponsored Post

How Can EHRs Support the Shift to Value-Based Care and Reduce Clinician Burnout?

MedCity News Editor in Chief Arundhati Parmar moderated a webinar with Elation Health executives Dr Sara Pastoor, head of primary care advancement, and Meaghan Sullivan, senior sales engineer.

By Stephanie Baum

Health Tech

GEM HEALTH Secures $7M to Advance Virtual Sleep Care

GEM HEALTH's Series A round was co-led by HealthTrend Capital and LFE Capital and included participation from existing investors Base10 Partners and Mairs & Power Venture Capital.

By Marissa Plescia

MedCity Influencers

Better AI + Correct Provider Guidance = Fewer Denials

How do we tip the scale to lower the rate of denials? While AI has been the initial decision-maker for years, it must become better trained. And to do that, it needs help.

By Christine Smith Stetler

MedCity Influencers

Keys to Provider Patient Communications Amidst President Trump’s Massive Policy Shifts

Exactly what the administration is ultimately able to accomplish will be anyone’s guess, but here are some key policy and market shifts healthcare leaders and their PR teams should watch closely and be prepared to communicate around.

By Ryan Lilly

Sponsored Post

Making Automation a Mainstream Function in Healthcare Practices

In a webinar sponsored by Jotform, scheduled for Thursday, March 13 at 2 pm ET, panelists will discuss how health tech companies approach data automation and how practices implement it.

By Stephanie Baum

Health Tech Artificial Intelligence,

6 HIMSS Announcements You Don’t Want to Miss

This year's HIMSS conference featured many news announcements — from advanced partnerships to product launches to new research. In this list, MedCity News compiled short summaries for six of the conference's most notable announcements.

By Katie Adams

Pharmacy

Where Does the Pharmacy Guild Stand in Its Effort to Build a National Pharmacy Union?

So far, 13 pharmacies have filed to join the Pharmacy Guild, 11 of which have won their election with the National Labor Relations Board while the other two are waiting for their election date.

By Marissa Plescia

BioPharma, Pharma

First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal

Jazz Pharmaceuticals’ acquisition of Chimerix brings a drug that could become the first approved therapy for a rare and aggressive form of brain cancer affecting children and young adults. An FDA decision for the molecule, dordaviprone, is expected in August.

By Frank Vinluan